Conatus Pharmaceuticals
Latest round
- Series B
Last raised
- Apr 2011
Total raised
- $63M
Investors
- 8
About Conatus Pharmaceuticals
Conatus Pharmaceuticals, Inc.Founded in 2005 and headquartered in San Diego, US, Conatus Pharmaceuticals specializes in innovative treatments for liver conditions. The company is focused on launching new products aimed at liver disease management and exploring collaborations to enter new markets by 2025.
Who invested in Conatus Pharmaceuticals
8 investors across 5 rounds
See all investors in Conatus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Conatus Pharmaceuticals
Who invested in Conatus Pharmaceuticals?
Conatus Pharmaceuticals has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Conatus Pharmaceuticals raised?
Conatus Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Conatus Pharmaceuticals last raise money?
Conatus Pharmaceuticals's most recent round on record is a Series B, in Apr 2011.
What does Conatus Pharmaceuticals do?
Conatus Pharmaceuticals is a pharmaceuticals company.
Where is Conatus Pharmaceuticals headquartered?
Conatus Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Conatus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Conatus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Conatus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.